Letters sent to healthcare professionals in March 2018

2018-04-24T09:01:25+01:00

Letters were sent to healthcare professionals about Zinbryta▼ (daclizumab beta), Lynparza 50 mg capsules, and radium-223-dichloride (Xofigo▼).…